Co-Diagnostics

CODX

0.54554.30% ( -0.0245 )

Closed: Oct 23, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -0.08, within the reasonable range, cheaper than 24.77% of the time in the past 5 years, and the industry ranks 55/173, the industry Median -0.83.

-0.0809xP/E

Stock price$0.55Earnings per share$-6.74

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

014284256

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-12.30x	140.96%	$13.08B
GKOSUSGlaukos	-56.11x	75.37%	$10.55B
TFXUSTeleflex	-5.60x	118.39%	$5.77B
IRTCUSIRhythm	-286.62x	71.47%	$4.00B
PLSEUSPulse Biosciences	-47.24x	26.85%	$3.78B
ASSTUSStrive	-3.68x	63.23%	$3.59B
AXGNUSAxogen	-66.56x	16.18%	$2.23B
BFLYUSButterfly Network	-24.05x	31.45%	$1.80B
ATECUSAlphatec	-15.60x	41.67%	$1.72B
NVCRUSNovocure	-11.51x	1.23%	$1.71B
KMTSUSKestra Medical Tech	-11.25x	0.79%	$1.69B
ENOVUSEnovis	-1.10x	100.97%	$1.22B
DRTSUSAlpha Tau Medical	-13.13x	--	$1.22B
TNDMUSTandem Diabetes	-19.15x	77.60%	$1.21B
PRCTUSPROCEPT BioRobotics	-10.42x	3.47%	$1.14B
AORTUSArtivion	-356.01x	266.67%	$1.14B
CBLLUSCeribell	-15.78x	35.15%	$1.04B
BBNXUSBeta Bionics	-13.82x	11.45%	$1.01B
SIBNUSSI-BONE	-65.79x	8.85%	$962.70M
QDELUSQuidelOrtho	-0.90x	75.33%	$941.54M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.